-+ 0.00%
-+ 0.00%
-+ 0.00%

ASPIRE BIOPHARMA - TO PAY $30 MLN PLUS $800,000 DEFERRED REVENUE AS PURCHASE PRICE - SEC FILING

Reuters·06/12/2026 14:28:17

Please log in to view news